Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Carrilizumab, bevacizumab,capecitabine Sponsor: Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Carcinoma | HNSCC | Hospitals | Research | Skin Cancer | Squamous Cell Carcinoma | Xeloda